{"id":"W4400143369","doi":"10.1016/j.annonc.2024.05.186","title":"177P Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A meta-analysis and systematic review","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Servier; National Natural Science Foundation of China; Sierra Oncology; Incyte; Ipsen; BeiGene; Eisai; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Astellas Pharma; Novocure; Boston Scientific Corporation; Yuhan; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Amgen; Sanming Project of Medicine in Shenzhen; Pfizer; PharmaMar; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Lenvatinib; Medicine; Sorafenib; Hepatocellular carcinoma; Meta-analysis; Oncology; Radiology; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003843827,0.002082238,0.009940515,0.001498918,0.00040731,0.001743804,0.001396746,0.001558128,0.003844538],"category_scores_gemma":[0.008434007,0.001362443,0.02743377,0.002440582,0.0007054493,0.001374744,0.001035921,0.002122966,0.0004703727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001765328,"about_ca_system_score_gemma":0.001428543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004581763,"about_ca_topic_score_gemma":0.01381535,"domain_scores_codex":[0.9973972,0.001112518,0.000547873,0.0005528661,0.0002189815,0.0001705389],"domain_scores_gemma":[0.9963543,0.002055718,0.001072675,0.0001685516,0.0002069223,0.0001418766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01969583,0.00008150492,0.008036077,0.09561758,0.8605805,0.00009944622,0.00008378205,0.0008056989,0.0007341241,0.0000916242,0.0005730785,0.01360087],"study_design_scores_gemma":[0.003364702,0.0007352227,0.004193999,0.002038226,0.9881882,0.00004578213,0.00002934156,0.0001860647,0.0001398271,0.0001125788,0.0009436697,0.00002231171],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04921151,0.9468468,0.001255231,0.0003703386,0.0005112989,0.0002532183,0.0008053951,0.0000749649,0.0006713184],"genre_scores_gemma":[0.7679372,0.2254026,0.002178201,0.001680028,0.0005103038,0.0004249006,0.0008783622,0.00007315096,0.0009152966],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.009940515,"threshold_uncertainty_score":0.02032834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1545641638173003,"score_gpt":0.33642400701898,"score_spread":0.1818598432016797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}